Aptevo Therapeutics Inc. · NASDAQ:APVO

Lamothe Jeffrey G. exercised options for 961 Aptevo Therapeutics Inc. shares (Form 4)

Traded Aug 6, 2026 · Filed Aug 10, 2026

On Aug 6, 2026, Lamothe Jeffrey G. (Director, President and CEO) exercised options for 961 Aptevo Therapeutics Inc. shares, leaving 961 shares. Filed Aug 10, 2026 (Form 4).

Options exercised
961 shares
Holding after
961 shares
Trading plan
No
Role
Director, President and CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 6, 2026Common StockOption exercise961961Direct

Source

View original at SEC

Related